Related Topics News -

     
 Title only   |   Print 
     
恆瑞醫藥SHR-3201注射液獲批臨床試驗

2026-10-14T  
恆瑞醫藥氟唑帕利膠囊獲EMA受理上市申請

2026-10-08T  
《大行》摩通:EADV數據反映恆瑞醫藥正加強免疫學業務發展

2026-10-07T  
《大行》美銀證券:中國醫藥/生物科技三項合作強化板塊動能 上調恆瑞及中生製藥目標價

2026-10-02T  
《大行》大和:恆瑞與諾和諾德就HRS-1596達許可協議 交易總額及預付款均具吸引力

2026-09-30T  
恆瑞與諾和諾德就口服減重藥HRS-1596達成獨家許可 潛在總交易額最高26億美元

2026-09-29T  
恆瑞醫藥周三回購25萬股A股 涉1,137萬人幣

2026-09-23T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.